What 18 Analyst Ratings Have To Say About Boston Scientific
Portfolio Pulse from Benzinga Insights
Over the last 3 months, 18 Wall Street analysts have provided ratings for Boston Scientific (NYSE:BSX), with an average price target of $62.22, which is above the current price of $56.295. The consensus among these analysts is positive, with 10 bullish and 7 somewhat bullish ratings. The average price target has seen a 3.49% increase over the past month.
December 13, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific has received a positive outlook from analysts, with 17 out of 18 ratings being bullish or somewhat bullish and an average price target of $62.22, indicating a potential upside from the current price.
The overwhelmingly positive ratings from analysts, combined with an average price target that is significantly higher than the current stock price, suggest that the market may react positively in the short term. The recent increase in the average price target further supports this potential upside.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100